NO942378D0 - - Google Patents

Info

Publication number
NO942378D0
NO942378D0 NO942378A NO942378A NO942378D0 NO 942378 D0 NO942378 D0 NO 942378D0 NO 942378 A NO942378 A NO 942378A NO 942378 A NO942378 A NO 942378A NO 942378 D0 NO942378 D0 NO 942378D0
Authority
NO
Norway
Application number
NO942378A
Other languages
Norwegian (no)
Other versions
NO942378L (no
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO942378L publication Critical patent/NO942378L/no
Publication of NO942378D0 publication Critical patent/NO942378D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO942378A 1991-12-23 1994-06-22 Anvendelse av arylindolderivater for behandling av psykoser NO942378L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK912065A DK206591D0 (da) 1991-12-23 1991-12-23 Behandling af psykoser
PCT/DK1992/000390 WO1993012790A1 (en) 1991-12-23 1992-12-21 Use of arylindole derivatives for the treatment of psychoses

Publications (2)

Publication Number Publication Date
NO942378L NO942378L (no) 1994-06-22
NO942378D0 true NO942378D0 (en:Method) 1994-06-22

Family

ID=8109829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942378A NO942378L (no) 1991-12-23 1994-06-22 Anvendelse av arylindolderivater for behandling av psykoser

Country Status (11)

Country Link
EP (1) EP0618799A1 (en:Method)
JP (1) JPH07502517A (en:Method)
AU (1) AU668537B2 (en:Method)
CA (1) CA2126571A1 (en:Method)
CZ (1) CZ153994A3 (en:Method)
DK (1) DK206591D0 (en:Method)
NO (1) NO942378L (en:Method)
RU (1) RU94031165A (en:Method)
SK (1) SK75794A3 (en:Method)
WO (1) WO1993012790A1 (en:Method)
ZA (1) ZA9210001B (en:Method)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5554030A (en) * 1994-06-30 1996-09-10 Minnesota Mining And Manufacturing Company Method for bonding non-amalgam restorative materials to dental surfaces
EP0932407A4 (en) * 1996-03-25 2002-04-24 Lilly Co Eli TECHNIQUE FOR TREATING MIGRAINE PAIN

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8908085D0 (en) * 1989-04-11 1989-05-24 Lundbeck & Co As H New therapeutic use
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
DK238190D0 (da) * 1990-10-03 1990-10-03 Lundbeck & Co As H Depotderivater
DK8492D0 (da) * 1992-01-23 1992-01-23 Lundbeck & Co As H Behandling af psykoser

Also Published As

Publication number Publication date
RU94031165A (ru) 1996-06-20
AU668537B2 (en) 1996-05-09
JPH07502517A (ja) 1995-03-16
NO942378L (no) 1994-06-22
CZ153994A3 (en) 1995-06-14
AU3345293A (en) 1993-07-28
CA2126571A1 (en) 1993-07-08
EP0618799A1 (en) 1994-10-12
DK206591D0 (da) 1991-12-23
WO1993012790A1 (en) 1993-07-08
ZA9210001B (en) 1994-01-13
SK75794A3 (en) 1995-04-12

Similar Documents

Publication Publication Date Title
CH0502314H1 (en:Method)
DE4290950T1 (en:Method)
DE4290919T1 (en:Method)
DE4290412T1 (en:Method)
DK0518777T3 (en:Method)
DE4290402T1 (en:Method)
DE4290741T1 (en:Method)
DE4291109T1 (en:Method)
DE4290056T1 (en:Method)
ATA37391A (en:Method)
ECSM91562U (en:Method)
ECSM91530U (en:Method)
ECSDI910041S (en:Method)
ECSM91543U (en:Method)
DE9101049U1 (en:Method)
ECSM91525U (en:Method)
IN174133B (en:Method)
ECSM91563U (en:Method)
AU8463091A (en:Method)
CN3009761S (en:Method)
AU7714891A (en:Method)
CN3009748S (en:Method)
EP0533338A3 (en:Method)
AU8969491A (en:Method)
CN3009203S (en:Method)